Show simple item record

Managing women with gestational diabetes mellitus in the postnatal period

dc.contributor.authorKim, Catherineen_US
dc.date.accessioned2010-06-01T19:07:58Z
dc.date.available2010-06-01T19:07:58Z
dc.date.issued2010-01en_US
dc.identifier.citationKim, Catherine (2010). "Managing women with gestational diabetes mellitus in the postnatal period." Diabetes, Obesity and Metabolism 12(1): 20-25. <http://hdl.handle.net/2027.42/72319>en_US
dc.identifier.issn1462-8902en_US
dc.identifier.issn1463-1326en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72319
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19788432&dopt=citationen_US
dc.format.extent490949 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights© 2010 Blackwell Publishing Ltden_US
dc.subject.otherGestational Diabetesen_US
dc.subject.otherPostpartumen_US
dc.subject.otherWomenen_US
dc.titleManaging women with gestational diabetes mellitus in the postnatal perioden_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartments of Medicine and Obstetrics & Gynecology, University of Michigan, Ann Arbor, MI, USAen_US
dc.identifier.pmid19788432en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72319/1/j.1463-1326.2009.01147.x.pdf
dc.identifier.doi10.1111/j.1463-1326.2009.01147.xen_US
dc.identifier.sourceDiabetes, Obesity and Metabolismen_US
dc.identifier.citedreferenceO’Sullivan J, Mahan C. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964; 13: 278 – 285.en_US
dc.identifier.citedreferenceO’Sullivan J. Diabetes mellitus after GDM. Diabetes 1991; 29 (Suppl. 2): 131 – 135.en_US
dc.identifier.citedreferenceBellamy L, Casas J, Hingorani A, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009; 373: 1773 – 1779.en_US
dc.identifier.citedreferenceCheung N, Byth K. Population health significance of gestational diabetes. Diabetes Care 2003; 26: 2005 – 2009.en_US
dc.identifier.citedreferenceKim C, Berger D, Chamany S. Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care 2007; 30: 1314 – 1319.en_US
dc.identifier.citedreferenceBuchanan T, Xiang A, Kjos S et al. Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes 1998; 47: 1302 – 1310.en_US
dc.identifier.citedreferenceBuchanan T, Catalano P. The pathogenesis of GDM: implication for diabetes after pregnancy. Diabetes Rev 1995; 3: 584 – 601.en_US
dc.identifier.citedreference8 National Institute for Health and Clinical Excellence (NICE). Diabetes in Pregnancy: Management of Diabetes and its Complications from Preconception to the Postnatal Period. London: National Collaborating Centre for Women's and Children's Health; 2008.en_US
dc.identifier.citedreferenceMetzger B, Buchanan T, Coustan D et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007; 30: S251 – S260.en_US
dc.identifier.citedreference10 ACOG Committee on Obstetric Practice. Postpartum screening for abnormal glucose tolerance in women who had gestational diabetes mellitus. Obstet Gynecol 2009; 113: 1419 – 1421.en_US
dc.identifier.citedreference11 World Health Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization; 1999.en_US
dc.identifier.citedreference12 World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: A report of WHO/IDF consultation. Geneva: World Health Organization; 2006.en_US
dc.identifier.citedreference13 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31 (Suppl. 1): S55 – S60.en_US
dc.identifier.citedreference14 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160 – 3167.en_US
dc.identifier.citedreferenceNathan D, Davidson M, DeFronzo R et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30: 753 – 759.en_US
dc.identifier.citedreferenceHarris M, Eastman R, Cowie C, Flegal K, Eberhardt M. Comparison of diabetes diagnostic categories in the U.S. population according to 1997 American Diabetes Association and 1980–1985 World Health Organization diagnostic criteria. Diabetes Care 1997; 20: 1859 – 1862.en_US
dc.identifier.citedreference17 DECODE Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? BMJ 1998; 317: 371 – 375.en_US
dc.identifier.citedreferenceMooy J, Grootenhuis P, de Vries H et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 1996; 39: 298 – 305.en_US
dc.identifier.citedreferenceFeskens E, Bowles C, Kromhout D. Intra- and interindividual variability of glucose tolerance in an elderly population. J Clin Epidemiol 1991; 44: 947 – 953.en_US
dc.identifier.citedreferenceHolt R, Goddard J, Clark P, Coleman M. A postnatal fasting plasma glucose is useful in determining which women with gestational diabetes should undergo a postnatal oral glucose tolerance test. Diabet Med 2003; 20: 594 – 598.en_US
dc.identifier.citedreference21 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183 – 1197.en_US
dc.identifier.citedreferenceRay J, O’Brien T, Chan W. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Q J Med 2001; 94: 435 – 444.en_US
dc.identifier.citedreferenceHarris M, Flegal K, Cowie C et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey. Diabetes Care 1998; 21: 518.en_US
dc.identifier.citedreferenceLawrence J, Contreras R, Sacks D. Trends in the Prevalence of Pre-Existing Diabetes and Gestational Diabetes Mellitus among a Racially/Ethnically Diverse Population of Pregnant Women, 1999–2005. Diabetes Care 2008; 31: 899 – 904.en_US
dc.identifier.citedreference25 The Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342: 381 – 389.en_US
dc.identifier.citedreferenceKim C, Herman W, Vijan S. Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care 2007; 30: 1102 – 1106.en_US
dc.identifier.citedreferenceKnowler W, Hamman R, Edelstein S et al. Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes 2005; 54: 1150 – 1156.en_US
dc.identifier.citedreferenceTuomilehto J, Lindstrom J, Eriksson J et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343 – 1350.en_US
dc.identifier.citedreferenceRatner R. Women with a history of gestational diabetes in the Diabetes Prevention Program. Fourth International Workshop-Conference on Gestational Diabetes Mellitus, 11/13/2005 Chicago, IL; 2005.en_US
dc.identifier.citedreferenceRatner R. Prevention of type 2 diabetes in women with previous gestational diabetes. Diabetes Care 2007; 30 (Suppl. 2): S242 – S245.en_US
dc.identifier.citedreferenceKim C, Sinco B, Kieffer E. Racial and ethnic variation in access to healthcare, provision of healthcare services, and rating of health among women with a history of gestational diabetes mellitus. Diabetes Care 2007; 30: 1459 – 1465.en_US
dc.identifier.citedreferenceO’Toole M, Sawicki M, Artal R. Structured diet and physical activity prevent postpartum weight retention. J Womens Health 2003; 12: 991 – 998.en_US
dc.identifier.citedreferenceLeermarkers E, Anglin K, Wing R. Reducing postpartum weight retention through a correspondence intervention. Int J Obes 1998; 22: 1103 – 1109.en_US
dc.identifier.citedreferenceLovelady C, Garner K, Moreno K, Williams J. The effect of weight loss in overweight, lactating women on the growth of their infants. N Engl J Med 2000; 342: 449 – 453.en_US
dc.identifier.citedreferenceBuchanan T, Xiang A, Peters R et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002; 51: 2796 – 2803.en_US
dc.identifier.citedreferenceXiang A, Peters R, Kjos S et al. Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 2006; 55: 517 – 522.en_US
dc.identifier.citedreferenceMottola M. The role of exercise in the prevention and treatment of gestational diabetes mellitus. Curr Diab Rep 2008; 8: 299 – 304.en_US
dc.identifier.citedreferenceGunderson E, Lewis C, Tsai A et al. A 20-year prospective study of childbearing and incidence of diabetes in young women, controlling for glycemia before conception: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetes 2007; 56: 2990 – 2996.en_US
dc.identifier.citedreferenceBaptiste-Roberts K, Barone B, Gary T et al. Risk factors for type 2 diabetes among women with gestational diabetes: a systematic review. Am J Med 2009; 122: 207 – 214.en_US
dc.identifier.citedreferenceKennedy K, Visness C. Contraceptive efficacy of lactational amenorrhea. Lancet 1992; 339: 227 – 230.en_US
dc.identifier.citedreferenceOlson C, Strawderman M, Hinton P, Pearson T. Gestational weight gain and postpartum behaviors associated with weight change from early pregnancy to 1 year postpartum. Int J Obes Relat Metab Disord 2003; 27: 117 – 127.en_US
dc.identifier.citedreferenceMcManus R, Cunningham I, Watson A, Harker L, Finegood D. Beta-cell function and visceral fat in lactating women with a history of gestational diabetes. Metabolism 2001; 50: 715 – 719.en_US
dc.identifier.citedreferenceKjos S, Peters R, Xiang A, Henry O, Montoro M, Buchanan T. Predicting future diabetes in Latino women with gestational diabetes. Diabetes 1995; 44: 586 – 591.en_US
dc.identifier.citedreferenceBuchanan T, Xiang A, Kjos S, Trigo E, Lee W, Peters R. Antepartum predictors of the development of type 2 diabetes in Latino women 11–26 months after pregnancies complicated by gestational diabetes. Diabetes 1999; 48: 2430 – 2436.en_US
dc.identifier.citedreferenceStuebe A, Rich-Edwards J, Willett W, Manson J, Michels K. Duration of lactation and incidence of type 2 diabetes. JAMA 2005; 294: 2601 – 2610.en_US
dc.identifier.citedreferencePettitt D, Knowler W. Long-term effects of the intrauterine environment, birth weight, and breast-feeding in Pima Indians. Diabetes Care 1998; 21 (Suppl. 2): B138 – B141.en_US
dc.identifier.citedreferenceMayer-Davis E, Dabelea D, Lamichhane A et al. Breast-feeding and type 2 diabetes in the youth of three ethnic groups: the SEARCH for diabetes in youth case-control study. Diabetes Care 2008; 31: 470 – 475.en_US
dc.identifier.citedreferenceYoung T, Martens P, Taback S et al. Type 2 diabetes mellitus in children: prenatal and early infancy risk factors among Native Canadians. Arch Pediatr Adolesc Med 2002; 156: 651 – 655.en_US
dc.identifier.citedreferenceLabbok M, Hight-Laukaran V, Peterson A, Fletcher V, von Hertzen H, Van Look P. Multicenter study of the Lactational Amenorrhea Method (LAM): I. Efficacy, duration, and implications for clinical application. Contraception 1997; 55: 327 – 336.en_US
dc.identifier.citedreferenceSkouby S, Kuhl C, Molsted-Pedersen L, Petersen K, Christensen M. Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes. Am J Obstet Gynecol 1985; 153: 495 – 500.en_US
dc.identifier.citedreferenceSkouby S, Molsted-Pedersen L, Kuhl C. Low dosage oral contraception in women with previous gestational diabetes. Obstet Gynecol 1981; 59: 325 – 328.en_US
dc.identifier.citedreferenceLopez L, Grimes D, Schulz K. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. Cochrane Database Syst Rev 2007; CD006133.en_US
dc.identifier.citedreferenceKjos S, Peters R, Xiang A, Thomas D, Schaefer U, Buchanan T. Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA 1998; 280: 533 – 538.en_US
dc.identifier.citedreferencePetitti D. Clinical practice: combination estrogen-progestin oral contraceptives. N Engl J Med 2003; 349: 1443 – 1450.en_US
dc.identifier.citedreferenceMadden T, Blumenthal P. Contraceptive vaginal ring. Clin Obstet Gynecol 2007; 50: 878 – 885.en_US
dc.identifier.citedreferenceHatcher R, Trussell J, Nelson A, Cates Jr W, Stewart F, Kowal D. Contraceptive Technology. New York City, NY: Ardent Media, Inc.; 2007.en_US
dc.identifier.citedreferenceGoa K, Warner G, Easthope S. Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception. Treat Endocrinol 2003; 2: 191 – 206.en_US
dc.identifier.citedreferenceChi I. The safety and efficacy issues of progestin-only oral contraceptives–an epidemiologic perspective. Contraception 1993; 47: 1 – 21.en_US
dc.identifier.citedreferenceKim C, Seidel K, Begier E, Kwok Y. Diabetes and depot medroxyprogesterone contraception in Navajo women. Arch Intern Med 2001; 161: 1766 – 1771.en_US
dc.identifier.citedreferenceXiang A, Kawakubo M, Kjos S, Buchanan T. Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care 2006; 29: 613 – 617.en_US
dc.identifier.citedreferenceKahn H, Curtis K, Marchbanks P. Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk. Diabetes Care 2003; 26: 216 – 225.en_US
dc.identifier.citedreferenceThonneau P, Almont T. Contraceptive efficacy of intrauterine devices. Am J Obstet Gynecol 2008; 198: 248 – 253.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.